YWT-29998-76255
2 vaccinations
7 coded responses
22 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 752 / TX
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Moderna
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Redness · Be unable to do your normal daily activitiesFree text: Soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-16
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site swelling — Feeling: GoodFree text: There was increased swelling and redness at the vaccination injection site on my arm. This appeared after the initial soreness had already subsided.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
-
2021-01-30
Dose 2 — Moderna
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: I am reporting symptoms experienced on 1/31/21 and 2/1/21, 12 they 48 hrs after 2nd doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Fair · Site: Pain, Redness, SwellingFree text: Some vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Good · Site: Redness, SwellingFree text: Some vertigo, difficulty keeping thoughts focusedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention, Memory impairment — Feeling: Good · Site: RednessFree text: Some difficulty focusing and sudden forgetting of what I'm thinking of.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — day 7, dose 2MedDRA: Fatigue — Feeling: GoodFree text: A bit of fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-31
- 2022-01-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna | |
| 2 | 2021-01-30 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-04 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Soreness at injection site
Release 2 — day 14, dose 1
Symptoms: There was increased swelling and redness at the vaccination injection site on my arm. This appeared after the initial soreness had already subsided.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): I am reporting symptoms experienced on 1/31/21 and 2/1/21, 12 they 48 hrs after 2nd dose
Systemic reaction (other): Some vertigo
Systemic reaction (other): Some vertigo, difficulty keeping thoughts focused
Systemic reaction (other): Some difficulty focusing and sudden forgetting of what I'm thinking of.
Release 3 — day 7, dose 2
Systemic reaction (other): A bit of fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Memory impairment | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release